BELLANDO RANDONE, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 10.497
EU - Europa 9.338
AS - Asia 6.231
SA - Sud America 1.005
AF - Africa 159
OC - Oceania 111
Continente sconosciuto - Info sul continente non disponibili 6
Totale 27.347
Nazione #
US - Stati Uniti d'America 10.382
RU - Federazione Russa 3.111
IT - Italia 2.749
CN - Cina 1.731
SG - Singapore 1.703
PL - Polonia 1.423
HK - Hong Kong 1.061
BR - Brasile 799
KR - Corea 677
IE - Irlanda 591
SE - Svezia 389
VN - Vietnam 361
IN - India 261
DE - Germania 225
FI - Finlandia 196
NL - Olanda 137
GB - Regno Unito 131
FR - Francia 129
AU - Australia 105
ID - Indonesia 103
JO - Giordania 89
AR - Argentina 86
ES - Italia 67
CH - Svizzera 63
CA - Canada 60
BD - Bangladesh 41
CI - Costa d'Avorio 40
TR - Turchia 37
IQ - Iraq 35
MX - Messico 35
UA - Ucraina 32
ZA - Sudafrica 32
EC - Ecuador 27
MA - Marocco 25
JP - Giappone 24
CO - Colombia 22
EG - Egitto 17
VE - Venezuela 16
BJ - Benin 15
PY - Paraguay 15
AT - Austria 14
UY - Uruguay 13
PE - Perù 12
LT - Lituania 10
PK - Pakistan 10
CL - Cile 9
KZ - Kazakistan 9
PH - Filippine 9
RS - Serbia 9
BE - Belgio 7
IR - Iran 7
KE - Kenya 7
RO - Romania 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
CZ - Repubblica Ceca 6
EU - Europa 6
IL - Israele 6
LV - Lettonia 6
UZ - Uzbekistan 6
BO - Bolivia 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
GE - Georgia 5
NO - Norvegia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PA - Panama 5
SA - Arabia Saudita 5
AL - Albania 4
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
MY - Malesia 4
TW - Taiwan 4
BH - Bahrain 3
HU - Ungheria 3
JM - Giamaica 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
LB - Libano 3
OM - Oman 3
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
DZ - Algeria 2
GR - Grecia 2
MK - Macedonia 2
ML - Mali 2
MU - Mauritius 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SL - Sierra Leone 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
CY - Cipro 1
ET - Etiopia 1
GY - Guiana 1
Totale 27.334
Città #
Santa Clara 2.500
Warsaw 1.409
Singapore 1.195
Ashburn 1.169
Fairfield 961
Hong Kong 922
Seoul 670
Hefei 588
Dublin 582
Chandler 495
Woodbridge 473
Seattle 399
Florence 390
Houston 364
Beijing 361
Cambridge 355
Wilmington 300
Milan 207
Lawrence 206
Rome 201
Altamura 193
Moscow 176
Los Angeles 166
Princeton 166
Ann Arbor 156
Buffalo 142
Mumbai 131
Ho Chi Minh City 129
Boston 126
Munich 102
Melbourne 99
Kent 86
Shanghai 79
Jakarta 75
Hanoi 73
São Paulo 70
Naples 69
The Dalles 65
Paris 64
New York 61
Dallas 60
San Diego 58
Boardman 57
Turku 56
Turin 55
Pune 51
Bern 47
Clifton 47
Bologna 45
Medford 43
Dong Ket 42
Abidjan 40
Helsinki 40
Falls Church 39
Chicago 38
Redondo Beach 38
London 34
Bengaluru 33
Bari 27
Lappeenranta 27
Norwalk 27
Rio de Janeiro 27
Yubileyny 26
Barcelona 23
Brooklyn 23
Catania 23
Johannesburg 23
Jacksonville 22
Phoenix 22
Toronto 21
Cagliari 20
West Jordan 20
Montreal 19
Tianjin 19
Belo Horizonte 18
Tokyo 18
Atlanta 17
Frankfurt am Main 17
Guangzhou 17
Hillsboro 17
Genoa 16
Mexico City 16
Padova 16
Reggio Emilia 16
Cotonou 15
Denver 15
Andover 14
Baghdad 14
Campinas 14
Brescia 13
Düsseldorf 13
Fiesole 13
Guayaquil 13
Izmir 13
Poplar 13
Salt Lake City 13
Stockholm 13
Brasília 12
Palermo 12
Porto Alegre 12
Totale 17.547
Nome #
ENDOMETRIOSI E MALATTIE REUMATICHE: LA PUNTA DELL’ICEBERG DEI NUMEROSI DISTURBI MESTRUALI IN CORSO DI MALATTIA REUMATICA 1.722
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 336
Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide 328
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis 305
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis 302
Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient. 286
Interstitial lung disease in systemic sclerosis: Where do we stand? 269
Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis 247
Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis 247
Very Early Diagnosis of Systemic Sclerosis (Diagnosi molto precoce della Sclerosi Sistemica) VEDOSS, 2010-2015 (2020). Validazione dei segni e sintomi in uno studio prospettico osservazionale di coorte 244
Sintomatologia gastrointestinale e qualità di vita dei pazienti affetti da Sclerosi Sistemica 237
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 219
The "myth" of loss of angiogenesis in systemic sclerosis: A pivotal early pathogenetic process or just a late unavoidable event? 219
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population 215
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis 211
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 203
Agonistic anti-human Fas monoclonal antibody induces fibroblast-like synoviocyte apoptosis in haemophilic arthropathy: potential therapeutic implications 202
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 200
Vascular leaking, a pivotal and early pathogenetic event in systemic sclerosis: should the door be closed? 189
Effect of Dysmetabolisms and Comorbidities on the Efficacy and Safety of Biological Therapy in Chronic Inflammatory Joint Diseases 180
A rare case of Candida glabrata spondylodiscitis: case report and literature review 179
Implantable cardioverter defibrillator prevents sudden cardiac death in systemic sclerosis. 179
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 173
STRATEGIE PER IMPLEMENTARE NEL CONTESTO ITALIANO LE “RECOMMENDATIONS FOR THE IMPLEMENTATION OF SELF-MANAGEMENT STRATEGIES IN PATIENTS WITH INFLAMMATORY ARTHRITIS” DI EULAR (2021) 173
Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro 173
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 173
Decrease of LL-37 in systemic sclerosis: a new marker for interstitial lung disease? 173
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 172
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 172
Calcinosis in systemic sclerosis: subsets, distribution and complications 171
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 169
Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis 169
Angiostatic and Angiogenic Chemokines in Systemic Sclerosis: An Overview 166
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 165
Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis 163
A SYSTEMATIC LITERATURE REVIEW (SLR) ON NURSING SENSITIVE OUTCOMES IN SYSTEMIC SCLEROSIS 157
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 156
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 155
The safety of iloprost in systemic sclerosis in a real-life experience 155
POS0613 THE ROLE OF MICROBIOTA IN DIFFERENT DISEASE STAGES OF SYSTEMIC SCLEROSIS: A POSSIBLE IMPACT IN GASTROINTESTINAL TRACT DISEASE ACTIVITY? 154
Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report 154
Transitional connective tissue diseases: description of four cases 153
Preliminary Validation of the Digital Ulcer Clinical Assessment Score in Systemic Sclerosis. 153
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 152
Accuracy of lung ultrasound performed with handheld ultrasound device in internal medicine: an observational study 151
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 151
Glycolysis-derived acidic microenvironment as a driver of endothelial dysfunction in systemic sclerosis 151
Treatment options in systemic sclerosis 150
Systemic Sclerosis Association with Malignancy 149
Disease Activity Improvement in Rheumatoid Arthritis Treated with Tumor Necrosis Factor-α Inhibitors Correlates with Increased Soluble Fas Levels. 149
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 148
Digital ulcers predict a worse disease course in patients with systemic sclerosis 148
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 147
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 147
MENSTRUATION-RELATED DISORDERS IN WOMAN WITH RHEUMATIC DISEASE (RDS): BLEEDING AND PAIN 146
Clinical-Serological Characterization and Treatment Outcome of a Large Cohort of Italian Children with Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection and Pediatric Acute Neuropsychiatric Syndrome 145
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 145
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre 145
"Atlas of Capilaroscopy in Rheumatic Diseases" - Chapter: The microcirculation and Rheumatic Diseases 144
Antioxidant agents help primary Raynaud's phenomenon 144
THE CROSSTALK OF THE SKIN-ORAL-GUT MICROBIOME AXIS IN LIMITED AND DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS 144
Persistence of remission after lengthening of golimumab in inflammatory joint diseases 142
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. 142
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 142
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. 142
Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis 140
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis 140
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 138
Quantitative analysis of pulmonary vasculature in systemic sclerosis at spirometry-gated chest CT 138
Systemic Sclerosis Serum Significantly Impairs the Multi-Step Lymphangiogenic Process: in Vitro Evidence 136
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 134
Effects of rituximab in connective tissue disorders related interstitial lung disease 134
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 133
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 133
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 132
Covid-19 and rheumatic autoimmune systemic diseases: Role of pre-existing lung involvement and ongoing treatments 132
Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage 131
"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity. 131
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 131
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 130
DECIPHERING THE GUT MICROBIOTA OF VERY EARLY SYSTEMIC SCLEROSIS (VEDOSS) PATIENTS: A TAXONOMIC AND FUNCTIONAL CHARACTERIZATION 129
GASTROINTESTINAL INVOLVEMENT AND QUALITY OF LIFE IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 129
The role of the dermatologist in Raynaud's Phenomenon: a clinical challenge 129
Avascular bone necrosis: An underestimated complication of systemic sclerosis 129
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 128
Systemic Sclerosis Patients Experiencing Mindfulness-Based Stress Reduction Program: The Beneficial Effect on Their Psychological Status and Quality of Life 127
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 127
Immunosuppression for interstitial lung disease in systemic sclerosis. 127
La riabilitazione multidisciplinare del malato reumatico 127
Prognostic value of lung ultrasound B-lines in systemic sclerosis 127
The Yin-Yang Pharmacomicrobiomics on Treatment Response in Inflammatory Arthritides: A Narrative Review 126
Systemic sclerosis and infections. 126
Mycosis fungoides: from early stages to fatal central nervous system involvement 125
Patients' unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis 124
Increased circulating levels of interleukin-33 in systemic sclerosis correlate with early disease stage and microvascular involvement 124
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 122
Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases 122
Rheumatic diseases in migrant patients resident in Tuscany: epidemiological data analysis and single-center experience 122
The Rising Challenge of Poor Health Literacy of Patients with Systemic Sclerosis: Preliminary Data Identify Important Unmet Needs in an Italian Cohort 121
Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis 121
Totale 17.917
Categoria #
all - tutte 77.380
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.380


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021931 0 0 0 0 0 132 96 120 155 253 99 76
2021/2022962 19 69 94 35 49 65 26 97 68 34 124 282
2022/20232.577 280 566 105 142 136 413 365 110 224 43 102 91
2023/20242.018 45 148 229 113 122 235 130 343 80 249 191 133
2024/20259.839 362 978 570 1.504 2.324 1.091 438 742 475 353 462 540
2025/20267.039 1.284 1.615 1.261 1.193 1.468 218 0 0 0 0 0 0
Totale 27.707